Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells
Purpose Metastatic prostate cancer is associated with poor survival rate and limited treatment options. Overexpression of c-Myc and BIRC5 has been reported in prostate cancer cells which contribute to the development of the tumour environment. The specific tumour receptor mechanism of the death liga...
Saved in:
| Main Authors: | Corinne Kai Leng Chew, Hannah O'Toole, Daniela M Zisterer, Seema M. Nathwani, Jade K. Pollock |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Technological University Dublin
2024-12-01
|
| Series: | SURE Journal: (Science Undergraduate Research Experience Journal) |
| Subjects: | |
| Online Access: | https://arrow.tudublin.ie/sure_j/vol6/iss1/10 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma
by: Lingyi Fu, et al.
Published: (2025-04-01) -
Expression of anti-apoptothic protein survinin and its gene BIRC5 in primary breast carcinoma as a prognostic factor for the disease
by: E. A. Shlyakhtunov
Published: (2019-02-01) -
Exploring BIRC family genes as prognostic biomarkers and therapeutic targets in prostate cancer
by: Xiao-xiang Yu, et al.
Published: (2025-02-01) -
Gemcitabine resistance by CITED4 upregulation via the regulation of BIRC2 expression in pancreatic cancer
by: Eun-Jeong Jeong, et al.
Published: (2025-05-01) -
BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis
by: Yanxing Mai, et al.
Published: (2024-11-01)